Biomea Fusion Receivables

Biomea Fusion (BMEA) currently reports a receivables of $0 as of June 2026. That compares with $22K in the prior-year period — down 100.0% year over year. Use the charts on this page to explore Biomea Fusion's receivables history and peer comparisons.

Biomea Fusion's receivables decreased from $22K to $0 — a 100.0% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Biomea Fusion reported $0 in receivables as of June 2026. That compares with $22K in the prior-year period — down 100.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current receivables of $0, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Biomea Fusion, and consider following BMEA for alerts when major investors trade the stock.

Biomea Fusion is classified in the Healthcare sector. On receivables, it currently shows $0. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing BMEA with unrelated industries.